Answers are grounded in this paper and cite their sources.
You have accessJournal of UrologyProstate Cancer: Localized: Radiation Therapy (PD57)1 May 2024PD57-04 MAJOR COMPLICATIONS AND ADVERSE EVENTS OF SPACEOAR HYDROGEL: AN ANALYSIS OF THE MANUFACTURER AND USER FACILITY DEVICE EXPERIENCE DATABASE Jack C. Millot, Camilo Arenas-Gallo, Esther Silver, Mollie Goldman, Shany Picciotto, Angela Y. Jia, Nicholas G. Zaorsky, Daniel E. Spratt, Elisha T. Fredman, and Jonathan E. Shoag Jack C. MillotJack C. Millot , Camilo Arenas-GalloCamilo Arenas-Gallo , Esther SilverEsther Silver , Mollie GoldmanMollie Goldman , Shany PicciottoShany Picciotto , Angela Y. JiaAngela Y. Jia , Nicholas G. ZaorskyNicholas G. Zaorsky , Daniel E. SprattDaniel E. Spratt , Elisha T. FredmanElisha T. Fredman , and Jonathan E. ShoagJonathan E. Shoag View All Author Informationhttps://doi.org/10.1097/01.JU.0001008808.16085.aa.04AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: SpaceOARTM hydrogel is utilized to reduce rectal toxicity during prostate cancer radiation therapy. In clinical trials, no grade ≥3 adverse events were reported. With limited postmarket studies on complications, we aimed to investigate the range and prevalence of SpaceOAR-related adverse events. METHODS: We performed an analysis of SpaceOAR-related adverse events reported in the Manufacturer and User Facility Device Experience (MAUDE) database from January 2015 to May 2023. We identified the event type, associated device and patient problems, description, and severity of events stratified by the Common Terminology Criteria for Adverse Events version 5.0 (CTCAE) grading system. SpaceOAR sales data from 2015 to 2022 was obtained from Boston Scientific. RESULTS: A total of 206,619 SpaceOAR devices were sold from 2015 to 2022 (Figure 1). From January 2015 to May 2023, we identified 981 reports describing 990 SpaceOAR-related adverse events. Malfunctions were the most common event type (N=626, 63.8%), followed by patient injuries (N=350, 35.7%) with few reported deaths (N=5, 0.5%). Device positioning problems were the most frequent device issue (N=686, 69.9%). Pain was the most reported patient problem (N=216, 22.0%). Abscesses and fistulas related to the device were each reported in 91 (9.3%) events. A noteworthy portion of relevant adverse events occurred before the initiation of radiation (N=35, 22.4%), suggesting the device, rather than the radiation, was responsible. Most of the events were CTCAE grade 1 (N=470, 50.2%) and grade 2 (N=344, 36.7%) (Table 1). There were 123 (13.1%) SpaceOAR-related events that were grade ≥3. CONCLUSIONS: We identified multiple reports of SpaceOAR-related adverse events, many of which are more serious than reported in clinical trials. While SpaceOAR use is common, suggesting these events are rare, these data highlight the need for continued postmarket surveillance. This study informs physicians and patients about the risks of applying SpaceOAR. Download PPT Source of Funding: The work presented here was not directly funded by an outside organization or sponsor © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e1209 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Jack C. Millot More articles by this author Camilo Arenas-Gallo More articles by this author Esther Silver More articles by this author Mollie Goldman More articles by this author Shany Picciotto More articles by this author Angela Y. Jia More articles by this author Nicholas G. Zaorsky More articles by this author Daniel E. Spratt More articles by this author Elisha T. Fredman More articles by this author Jonathan E. Shoag More articles by this author Expand All Advertisement PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Millot et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: